Update date
31 Dec 2025
Shareable Research Card
TLX - Telix Pharmaceuticals Ltd Goodwill
This metric view shows TLX - Telix Pharmaceuticals Ltd goodwill history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2025
- Latest reported value
- $198,988,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2025
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2025.
- Latest reported value on this page: $198,988,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Goodwill
Latest reported goodwill: $198,988,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 20 Feb 2026.
Benchmark Context
How Goodwill compares with peers
Telix Pharmaceuticals Ltd sits in the lower half of the current goodwill sample.
Compared with
Compared with 120 companies reporting goodwill in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.5x the current sample midpoint. Goodwill is up about 199% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2017 to 31 Dec 2025.
- Nearby companies in this sample: Titan America SA and Neo Group Ltd.
- Current sample position: rank #71 of 120 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Telix Pharmaceuticals Ltd: Goodwill
Latest period: Q4 2025. Period end: 31 Dec 2025. Units: USD. Frequency: quarterly.
Goodwill is an SEC-reported metric from company XBRL facts.
Metric Snapshot
- Latest value
- $198,988,000
- Coverage range
- 31 Dec 2024 - 31 Dec 2025
- Fact rows
- 2
What This Metric Tells You
- Shows the reported level of goodwill over 31 Dec 2024 - 31 Dec 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 2 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare This Metric Across Companies
Compare latest available Goodwill levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Telix Pharmaceuticals Ltd appears at rank #71 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Anheuser-Busch InBev SA/NV (bud) | $117,908,000,000 | Instant - 31 Dec 2025 | Open Anheuser-Busch InBev SA/NV Goodwill |
| 2 | BROOKFIELD Corp /ON/ (bn) | $43,355,000,000 | Instant - 31 Dec 2025 | Open BROOKFIELD Corp /ON/ Goodwill |
| 3 | SAP SE (sap) | $25,576,000,000 | Instant - 31 Dec 2017 | Open SAP SE Goodwill |
| 4 | NOVARTIS AG (nvs) | $25,567,000,000 | Instant - 31 Dec 2025 | Open NOVARTIS AG Goodwill |
| 5 | ASTRAZENECA PLC (azn) | $21,242,000,000 | Instant - 31 Dec 2025 | Open ASTRAZENECA PLC Goodwill |
| 6 | Brookfield Infrastructure Partners L.P. (bip) | $19,210,000,000 | Instant - 31 Dec 2025 | Open Brookfield Infrastructure Partners L.P. Goodwill |
Metric Details
- Metric
- Goodwill (Goodwill)
- Taxonomy
- ifrs-full
- Units tracked
- USD
- Frequency coverage
- quarterly
- History range
- 31 Dec 2024 - 31 Dec 2025
- Facts on this page
- 2
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)
Telix Pharmaceuticals Ltd Quarterly Goodwill (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $198,988,000 | +$132,402,000 | +199% | 31 Dec 2025 | 20-F | 20 Feb 2026 | 2025 | FY |
| Q4 2024 | $66,586,000 | 31 Dec 2024 | 20-F | 20 Feb 2026 | 2025 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.